← back to search

Frederic B. Thalheimer

Goethe University Frankfurt · DE
Area of research
Oncology · Genetics
Research interest
Research interests include CAR-T cell therapy research, Virus-based gene therapy research, Hematopoietic Stem Cell Transplantation, and Immune Cell Function and Interaction.
h-index
17
citations
2,157
works
43
NIH funding
primary concept
email

Recent publications

Enhanced conversion of T cells into CAR T cells by modulation of the MAPK/ERK pathway
Cell Reports Medicine 2025cited by 4position: middledoi
Early induction of cytokine release syndrome by rapidly generated CAR T cells in preclinical models
EMBO Molecular Medicine 2024cited by 13position: middledoi
CAR Gene Delivery by T‐cell Targeted Lentiviral Vectors is Enhanced by Rapamycin Induced Reduction of Antiviral Mechanisms
Advanced Science 2023cited by 14position: middledoi
CD62L as target receptor for specific gene delivery into less differentiated human T lymphocytes
Frontiers in Immunology 2023cited by 10position: middledoi
Substantially improved gene transfer to interneurons with second-generation glutamate receptor-targeted DART-AAV vectors
Journal of Neuroscience Methods 2023cited by 7position: middledoi
In Vivo Generation of CAR T Cells Selectively in Human CD4+ Lymphocytes
Molecular Therapy 2020cited by 173position: middledoi
Highly Efficient Generation of Transgenically Augmented CAR NK Cells Overexpressing CXCR4
Frontiers in Immunology 2020cited by 68position: middledoi
<i>In vivo</i> generated human CAR T cells eradicate tumor cells
OncoImmunology 2019cited by 94position: middledoi
Tumor-Specific Delivery of Immune Checkpoint Inhibitors by Engineered AAV Vectors
Frontiers in Oncology 2019cited by 58position: middledoi
GluA4-Targeted AAV Vectors Deliver Genes Selectively to Interneurons while Relying on the AAV Receptor for Entry
Molecular Therapy — Methods & Clinical Development 2019cited by 24position: middledoi
In vivo generation of human CD19‐CAR T cells results in B‐cell depletion and signs of cytokine release syndrome
EMBO Molecular Medicine 2018cited by 188position: middledoi
Vitamin A-Retinoic Acid Signaling Regulates Hematopoietic Stem Cell Dormancy
Cell 2017cited by 450position: middledoi
Vitamin A/ retinoic acid signaling regulates hematopoietic stem cell dormancy
Experimental Hematology 2017cited by 7position: middledoi
DNA-damage response gene GADD45A induces differentiation in hematopoietic stem cells without inhibiting cell cycle or survival
Stem Cells 2016cited by 58position: middledoi
Exit from HSC dormancy by a continuous upregulation of metabolism is controlled via vitamin A/ retinoic acid
Experimental Hematology 2016cited by 0position: middledoi
Transition out of HSC Dormancy By a Continuous Upregulation of Metabolism Is Controlled Via Dietary Vitamin A/ Retinoic Acid Signaling
Blood 2016cited by 0position: middledoi
Exit from dormancy provokes DNA-damage-induced attrition in haematopoietic stem cells
Nature 2015cited by 615position: middledoi
STAT5-regulated microRNA-193b controls haematopoietic stem and progenitor cell expansion by modulating cytokine receptor signalling
Nature Communications 2015cited by 59position: middledoi
Single-Stranded DNA-Binding Transcriptional Regulator FUBP1 Is Essential for Fetal and Adult Hematopoietic Stem Cell Self-Renewal
Cell Reports 2015cited by 37position: middledoi
Cytokine-Regulated GADD45G Induces Differentiation and Lineage Selection in Hematopoietic Stem Cells
Stem Cell Reports 2014cited by 46position: firstdoi
Altered HSC Metabolism in Response to Stress Leads to De Novo dna Damage and Cellular Attrition
Blood 2014cited by 0position: middledoi
Incomplete cytokinesis and re-fusion of small mononucleated Hodgkin cells lead to giant multinucleated Reed–Sternberg cells
Proceedings of the National Academy of Sciences 2013cited by 85position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Christian J. Buchholz · Goethe University Frankfurt10 papers (2018–2025)Michael A. Rieger · Fraunhofer Institute for Translational Medicine and Pharmacology9 papers (2013–2016)Timm Schroeder · ETH Zurich6 papers (2013–2016) · 4 papers (2019–2023)Andreas Trumpp · TRUMPF (Germany)4 papers (2014–2016)Tobias P. Dick · German Cancer Research Center4 papers (2014–2016)Annika M. Frank · Paul Ehrlich Institut3 papers (2018–2023) · 3 papers (2020–2024)Susanne Wingert · Ludwig-Maximilians-Universität München3 papers (2014–2016)Nadine Haetscher · Goethe University Frankfurt3 papers (2014–2016)Naphang Ho · Goethe University Frankfurt3 papers (2023–2024) · 3 papers (2023–2025)Maike Rehage · University Hospital Frankfurt3 papers (2014–2016) · 3 papers (2014–2016) · 3 papers (2019–2020)Letícia Prates Roma · Saarland University2 papers (2016–2016)Florian Buettner · German Cancer Society2 papers (2016–2016) · 2 papers (2023–2025)Pia Sommerkamp · European Molecular Biology Laboratory2 papers (2016–2016)Colin Clarke · Royal College of Surgeons in Ireland2 papers (2023–2025)